Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258

Completed

Conditions studied: Cancer

In brief

This study will evaluate whether chemotherapy teaching sessions improves patient's knowledge, preparedness and anxiety in relation to chemotherapy. This study will also evaluate the effect of age, race, native language, education level, type of cancer and chemotherapy regimen on the oncology teaching session.

Key facts

Study ID

NCT01827761

Run by

Brown University

People needed

196

Starts

2011-10-01

Expected to finish

2014-05-01

Last updated by the study team

2022-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients > 18 years of age who will be receiving chemotherapy (including targeted anticancer therapy) at a Brown University Oncology Research Group Affiliated Hospital for a period of 1-year after study activation.
• Patients who will be undergoing a chemotherapy teaching session at an institution affiliated with the Brown University Oncology Research Group.
• No prior chemotherapy or targeted anticancer treatment.
• Signed informed consent

You may not qualify if…

• Patients must meet eligibility criteria

Where it is running

• Memorial Hospital — Pawtucket, Rhode Island, United States
• Rhode Island Hospital (including Newport) — Providence, Rhode Island, United States
• The Miriam Hospital — Providence, Rhode Island, United States
• Roger Williams Medical Center — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.